SHERIDAN, Wyo., June 4, 2026 /PRNewswire/ -- The global veterinary vaccines market is projected to grow from USD 11 billion in 2025 to USD 15.6 billion by 2031, registering a CAGR of 6% during the forecast period (2026-2031), according to a new study by Wissen Research.
"The veterinary vaccines market is growing strongly because of rising worries about livestock diseases, zoonotic disease spread, and animal health. The Food and Agriculture Organization notes that livestock is responsible for almost 40% of global agricultural output. This makes disease prevention super important for food security and farm productivity. Increasing pet ownership, growing commercial livestock, and the adoption of advanced vaccine tech like mRNA and recombinant vaccines are also boosting the market. Additionally, government-led vaccination drives and increased efforts to stop diseases such as avian influenza, foot-and-mouth disease, and rabies, are ramping up demand in both livestock and companion animals," noted Mayur Jain, Research Expert at Wissen Research.
For customized insights tailored to your business needs, request a personalized version of this report athttps://www.wissenresearch.com/request-customization/?report=veterinary-vaccines-market
Technology Advancements Reshaping the Veterinary Vaccines Market
Tech advances are changing the veterinary vaccines market. We now have better vaccines like recombinant, vector-based, DNA, and mRNA types. Safety and effectiveness increased, plus we can make them quicker. Thanks to progress in reverse vaccinology and genomic sequencing, we're making vaccines for new diseases in animals faster. Also, new thermostable formulas and needle-free systems make vaccines easier to access, even in far-off areas. Multivalent vaccines that protect against various diseases in one shot are way more efficient and cheaper, cutting down animal handling costs. So, vaccination rates can rise globally, helping more animals stay healthy.
Key Market Drivers for the Veterinary Vaccines Market:
- Rising prevalence of zoonotic, transboundary, and livestock infectious diseases increases demand for preventive vaccination.
- Expansion of commercial livestock farming drives the need to improve herd health, productivity, and disease control.
- Growing pet ownership and increasing expenditure on companion animal healthcare support vaccine adoption.
- Government-led animal disease eradication and vaccination programs strengthen immunization coverage globally.
- Advancements in recombinant, vector-based, and mRNA vaccine technologies improve vaccine effectiveness and accessibility.
- Increasing focus on food security and reducing economic losses from animal disease outbreaks accelerates vaccine utilization.
Market Challenges for the Veterinary Vaccines Industry
- The long, complicated regulatory approval process really hinders veterinary vaccine makers. They must do a ton of safety, efficacy, and field tests. That leads to pricey development costs and a lengthy time-to-market. This can slow down innovation, especially for region-specific or emerging diseases.
- Vaccine stability and distribution pose big issues too. Many veterinary vaccines need cold-chain storage and shipping, which is tricky in developing areas with poor infrastructure. That makes it hard to get vaccines where they're needed most and drives up waste.
- There's also the problem of rapidly changing pathogens. Viruses mutate fast, and diseases evolve, reducing vaccine effectiveness and demanding new versions. Some livestock owners resist vaccines because of their costs, lack of knowledge, or inconsistent use. This all-hurts disease control and market expansion.
To gain deeper insights into market trends, competitive dynamics, and growth opportunities, request a complimentary sample copy of the report at: https://www.wissenresearch.com/request-a-sample/?report=veterinary-vaccines-market
Recent Strategic Developments in the Veterinary Vaccines Market
The deals being struck across the industry tell a clear story - companies are doubling down on recombinant DNA platforms, vector-based systems, and adjuvant innovations to improve immune response, increasingly through partnerships rather than solo efforts.
In July 2025, Hipra, S.A. (Spain) collaborated with Llamas Laboratories and Services (Argentina) strengthens its diagnostic service to improve animal health in Argentina. The main objective of this alliance is to strengthen and optimize the diagnostic service for animal production in Argentina. This will be achieved by expanding the range of locally available tests, increasing the value of results for decision-making, and reducing turnaround times, among other advantages.
In June 2025, Vaxxinova International B.V. (Netherlands) acquired the Avishield poultry vaccine portfolio from Dechra Pharmaceuticals Limited (UK), along with Dechra's poultry vaccine research and development team based in Zagreb, Croatia. This strategic acquisition enables Vaxxinova to expand its global footprint by adding a complete range of live vaccines for Infectious Bronchitis (IB), Gumboro Disease (IBD), and Newcastle Disease (ND) to its offerings.
Key Insights from Veterinary Vaccines Market Analysis
- Outbreaks of animal diseases are boosting the need for preventive vaccines globally.
- Livestock vaccines take the biggest slice of the market because poultry, cattle, swine, and fish farming are huge economically.
- Tech advances in recombinant, vector-based, and mRNA vaccines are driving the veterinary vaccine field forward.
- As more people get pets, there's growing spending on pet health care, spurring demand for dog and cat vaccines.
- State-supported disease control efforts and required vaccination programs keep pushing vaccine use in top livestock nations.
- In the Asia-Pacific, look for strong growth in vaccines, thanks to rising numbers of livestock, increasing protein consumption, and better vet care systems.
Key Players in the Veterinary Vaccines Market
Leading companies in the veterinary vaccines market are focusing on product innovation, strategic collaborations, and expanding animal health-focused capabilities to strengthen their competitive position.
Company | Key Focus Area |
Zoetis Inc. (US) | Companion animal and livestock vaccines with a focus on innovation and disease prevention. |
Merck & Co., Inc. (US) | Broad livestock and companion animal vaccine portfolio targeting infectious disease control. |
Boehringer Ingelheim International GMBH (Germany) | Advanced veterinary biologics and preventive healthcare solutions. |
Elanco Animal Health Incorporated (US) | Livestock productivity and companion animal disease prevention vaccines. |
Virbac S.A. (France) | Companion animal and farm animal vaccines with a focus on global veterinary health. |
Ceva Santé Animale (France) | Poultry, swine, and ruminant vaccines emphasizing disease management and herd health. |
Regional Analysis and Growth Opportunities in the Veterinary Vaccines Market
North America dominates the veterinary vaccines market because of high pet ownership, advanced vet care facilities, robust livestock systems, and big animal health firms. Continuous investment in cutting-edge tech and preventive care keeps boosting their market standing.
The Asia-Pacific region will see the most growth thanks to a huge livestock population, a spike in animal protein demand, more pet adoptions, and an expansion of vet services in places like China, India, and Southeast Asian nations. Plus, government efforts to stop disease outbreaks and beef up food security are opening up tons of new opportunities there.
In Europe, the market's mature but still growing steady thanks to strict animal welfare rules, full vaccination programs, and a bigger focus on stopping diseases in both farm and household animals. At the same time, Latin America, the Middle East, and Africa have plenty of untapped potential since commercial farming is expanding, vet infra is getting better, and people are becoming more aware of how animal diseases hit their wallets.
Vaccine Type & Technology Type Insights
In 2025, the livestock vaccines category became the frontrunner in the veterinary vaccines market. This happened because of our growing appetite for animal protein, the increase in livestock diseases that cross borders, and a bigger push from governments to vaccinate animals. The Food and Agriculture Organization (FAO) reported that global meat production surpassed 360 million metric tons yearly. Naturally, this resulted in a huge need for vaccines to keep cows, chickens, pigs, and farmed fish healthy. Poultry vaccines, in particular, are driving growth in the livestock vaccines market. The FAO estimates that over 28 billion chickens, turkeys, and other birds are raised each year. Plus, governments and organizations like the World Organisation for Animal Health (WOAH) are really pushing for widespread animal vaccination drives. Their goal is to lower zoonotic diseases and make sure we have enough food. As investment grows in commercial farming, especially in places like Asia Pacific and Latin America, more preventative vaccines are getting used in livestock operations.
By 2025, the live attenuated vaccine segment dominated a big chunk of the global veterinary vaccine market. These vaccines work really well because they create strong, long-lasting immune responses, are cheap, and easy to use for pets and livestock. They're great for stopping infectious animal disease outbreaks like Newcastle disease, infectious bronchitis, canine distemper virus, bovine viral diarrhea, and classical swine fever.
These vaccines protect against illnesses by stimulating both antibody and cell-mediated immunity with minimal doses, making them perfect for immunization programs. In particular, the poultry industry uses tons of these vaccines - more than 28 billion live birds are reared annually worldwide so there's a huge risk for avian influenza outbreaks.
To access the complete market analysis, detailed forecasts, competitive benchmarking, and strategic insights, purchase the full report at: https://www.wissenresearch.com/market-research-reports-pricings/veterinary-vaccines-market/
Market Segmentation Snapshot
The global veterinary vaccines market is segmented across vaccine type, diseases type, technology types, route of administration, end users and regions:
By Vaccines Type:
- Aquaculture Vaccines
- Companion Animal Vaccines
- Livestock Vaccines
- Porcine Vaccines
- Poultry Vaccines
- Other Veterinary Vaccines
By Diseases Type:
- Aquaculture Diseases
- Companion Animal Diseases
- Livestock Diseases
- Porcine Diseases
- Poultry Diseases
- Other Diseases
By Technology Type:
- Inactivated Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Other Vaccines Technology
By Route of Administration:
- Intraocular Route of Administration
- Intramuscular Route of Administration
- Intranasal/Spray Route of Administration
- Oral Route of Administration
- Subcutaneous Route of Administration
- Other Routes of Administration
By End User Industries:
- Veterinary Clinics
- Veterinary Hospitals
- Others
By Region:
- North America
- Europe
- Asia-Pacific
- Rest of the World
Browse the latest market research reports and uncover insights across multiple industries:https://www.wissenresearch.com/report/
Expert Profile | Mayur Jain, Wissen Research
Mayur Jain is a Research Expert at Wissen Research with multidomain expertise with more than 12+ years of experience in market research industry.
Email: mayur@wissenresearch.com
LinkedIn: https://www.linkedin.com/in/mayur-jain-0190542a/
About Wissen Research
Wissen Research is a global market intelligence and consulting firm specializing in healthcare, life sciences, technology, and emerging industries. The company provides data-driven insights, strategic market analysis, and industry forecasts to help organizations make informed business decisions and identify new growth opportunities across global markets
Company Contact:
Wissen Research LLC,
Gould St, Ste R,
Sheridan, WY 82801,
Phone: (+1) 510 240 9853
Email: info@wissenresearch.com
Website: https://www.wissenresearch.com/
Blog: https://www.wissenresearch.com/insights/
LinkedIn: https://www.linkedin.com/company/wissen-research
Logo - https://mma.prnewswire.com/media/2971885/5992352/Wissen_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/veterinary-vaccines-market-set-to-attain-us-15-6-billion-valuation-by-2031--growing-at-6-cagr-says-wissen-research-302791770.html
